Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its Variants

Victoria SA. Momyer, Samantha Dixon, Q. John Liu, Brian Wee, Tiffany Y. Chen, Anna Petropoulos, L. Jessica Sang
doi: https://doi.org/10.1101/2021.07.09.21260224
Victoria SA. Momyer
1Accure Health Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Dixon
2The New England Facial & Cosmetic Surgery Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Q. John Liu
1Accure Health Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Wee
1Accure Health Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tiffany Y. Chen
3Department of Pathology, Brigham and Women’s Hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Petropoulos
2The New England Facial & Cosmetic Surgery Center
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: apw3@me.com jessica@accurehealth.com
L. Jessica Sang
1Accure Health Inc.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: apw3@me.com jessica@accurehealth.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Given the ongoing transmission and emergence of SARS-Cov-2 variants globally, it is critical to have a timely assessment on individuals’ immune responses as well as population immunity. Important questions such as the durability of COVID-19 immunity or the efficacy of vaccines require large datasets to generate meaningful insights. However, due to the complexity and relatively high-cost of many immunity assays and the needs for blood-drawing specialists, these assays were mostly limited to small-scale clinical studies. Our work demonstrated the potential of a non-invasive, inexpensive and data-driven solution for large-scale immunity surveillance and for predictive modeling of vaccine efficacy. Combining a proprietary saliva processing method and an ultra-sensitive digital detection technology, we were able to rapidly gather information regarding personalized immune response following infection or vaccination, monitor temporal evolution, and optimize predictive models for variant protection.

Competing Interest Statement

V. SA. Momyer, Q.J. Liu, B. Wee and L.J. Sang are employees of Accure Health Inc.

Funding Statement

Nothing to report

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Biomedical Research Alliance of New York Institutional Review Board

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The main data supporting the results in this study are available within the paper and its supplementary information. The raw patient datasets generated and analyzed during the study are available from the corresponding authors on reasonable request, subject to approval from the Biomedical Research Alliance of New York Institutional Review Board.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted July 14, 2021.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its Variants
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its Variants
Victoria SA. Momyer, Samantha Dixon, Q. John Liu, Brian Wee, Tiffany Y. Chen, Anna Petropoulos, L. Jessica Sang
medRxiv 2021.07.09.21260224; doi: https://doi.org/10.1101/2021.07.09.21260224
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A Rapid Saliva Test for Monitoring Immune Protection against SARS -CoV-2 and its Variants
Victoria SA. Momyer, Samantha Dixon, Q. John Liu, Brian Wee, Tiffany Y. Chen, Anna Petropoulos, L. Jessica Sang
medRxiv 2021.07.09.21260224; doi: https://doi.org/10.1101/2021.07.09.21260224

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (940)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (418)
  • Epidemiology (8967)
  • Forensic Medicine (4)
  • Gastroenterology (417)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1320)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (211)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10764)
  • Intensive Care and Critical Care Medicine (570)
  • Medical Education (199)
  • Medical Ethics (52)
  • Nephrology (221)
  • Neurology (1815)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1891)
  • Public and Global Health (4107)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (361)
  • Respiratory Medicine (547)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (206)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)